Successfully treated severe COVID-19 and invasive aspergillosis in early hematopoietic cell transplantation setting.

Subjects

Subjects :

Adenosine Monophosphate administration & dosage
Adenosine Monophosphate analogs & derivatives
Alanine administration & dosage
Alanine analogs & derivatives
Amphotericin B administration & dosage
COVID-19 diagnosis
COVID-19 immunology
COVID-19 virology
Coinfection diagnosis
Coinfection immunology
Coinfection microbiology
Drug Therapy, Combination methods
Graft vs Host Disease immunology
Graft vs Host Disease prevention & control
Humans
Immunosuppressive Agents administration & dosage
Invasive Pulmonary Aspergillosis diagnosis
Invasive Pulmonary Aspergillosis immunology
Invasive Pulmonary Aspergillosis microbiology
Lung diagnostic imaging
Male
Methylprednisolone administration & dosage
Myeloablative Agonists administration & dosage
Myeloablative Agonists adverse effects
Nitriles
Precursor Cell Lymphoblastic Leukemia-Lymphoma immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy
Pyrazoles administration & dosage
Pyrimidines
SARS-CoV-2 immunology
SARS-CoV-2 isolation & purification
Severity of Illness Index
Tomography, X-Ray Computed
Transplantation Conditioning adverse effects
Transplantation Conditioning methods
Treatment Outcome
Young Adult
Coinfection drug therapy
Hematopoietic Stem Cell Transplantation adverse effects
Immunosuppressive Agents adverse effects
Invasive Pulmonary Aspergillosis drug therapy
COVID-19 Drug Treatment

Details

Language :

English

ISSN :

1399-3062

Volume :

23

Issue :

2

Database :

MEDLINE

Journal :

Transplant infectious disease : an official journal of the Transplantation Society

Publication Type :

Report

Accession number :

32959932

Full Text :

https://doi.org/10.1111/tid.13470